Denis Perez
Gynecology · Melbourne, FLNPI 1821190554
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 31.0% of the total. Reporting peaked in 2019 at $830 and has fallen 88.4% since, to $96 in 2023.
Across 69 payments — averaging $27.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$594
- GSK$195
- Astellas Pharma US Inc$152
- Therapeuticsmd, Inc.$144
- Daiichi Sankyo Inc.$125
- Biohaven Pharmaceutical Holding Company Ltd.$125
- plus $579 from 20 others
What the payments were for
- Food & beverage$1,85297%
- Education$623%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $594 |
| GSK | 4 | $195 |
| Astellas Pharma US Inc | 6 | $152 |
| Therapeuticsmd, Inc. | 2 | $144 |
| Daiichi Sankyo Inc. | 3 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $125 |
| Mayne Pharma Commercial LLC | 4 | $62 |
| Amgen | 4 | $61 |
| Hologic Sales And Service, LLC | 4 | $52 |
| AstraZeneca | 3 | $51 |
| UCB, Inc. | 2 | $44 |
| Roche Diagnostics Corporation | 2 | $40 |
| Amarin Pharma, Inc. | 2 | $35 |
| Sanofi Pasteur Inc. | 2 | $31 |
| Merck | 2 | $27 |
| Pfizer | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Applied Medical Resources Corporation | 1 | $19 |
| Millicent US Inc | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $13 |
| Exeltis, USA Inc. | 1 | $13 |
| Bayer | 1 | $12 |
| Organon | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$125
- ZEJULA$124
- IMVEXXY$122
- NURTEC ODT$116
- INJECTAFER$100
How this compares
$1,914 in reported general payments places this provider in the 70th percentile of 290 gynecology providers in Florida.
Other gynecology in Melbourne
- Marshall BovelskyMelbourne$52K
- Victor BenezraMelbourne$24K
- Paula MinerMelbourne$5K
- Aileen CaceresKissimmee$406K
- Parveen VahoraNew Port Richey$327K
- James KondrupVenice$310K
- Andrea GallowayThe Villages$252K
- Jessica VaughtOrlando$129K
- Steven ChavoustieMiami$113K
- Minda NeimarkFt Lauderdale$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.